Search

Your search keyword '"Moore, Kayla O."' showing total 15 results
Start Over Author "Moore, Kayla O."
15 results on '"Moore, Kayla O."'

4. Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease.

Author

Fowler, Xavier, Mehta, Kunal, Eid, Mark, Gladders, Barbara, Kearing, Stephen, Moore, Kayla O, Creager, Mark A, Austin, Andrea M, Feinberg, Mark W, Bonaca, Marc P, Greenland, Philip, McDermott, Mary M, and Goodney, Philip P

Subjects
PERIPHERAL vascular diseases, CONGESTIVE heart failure, FIBRINOLYTIC agents, MORTALITY risk factors, DEATH rate
Abstract

Introduction: Peripheral artery disease (PAD) is a well-described risk factor for mortality, but few studies have examined secular trends in mortality over time for patients with PAD. We characterized trends in mortality in patients with PAD in recent years among Medicare patients. Methods: We used Medicare claims to identify patients with a new diagnosis code for PAD between January 1, 2006 and December 31, 2018 using International Classification of Diseases (ICD) diagnosis codes. The primary outcome of interest was the 1-year all-cause age-adjusted mortality rate. Our secondary outcome was the 5-year all-cause mortality rate. Multivariable regression was used to identify factors which predict mortality at 1 year. Results: We identified 4,373,644 patients with a new diagnosis code for PAD during the study period. Between 2006 and 2018, 1-year all-cause age-adjusted mortality declined from 12.6% to 9.9% (p < 0.001). One-year crude all-cause mortality also declined from 14.6% to 9.5% (p < 0.001). Similar results were observed for 5-year age-adjusted mortality rates (40.9% to 35.2%, p < 0.001). Factors associated with increased risk of death at 1 year included age ⩾ 85 years (hazard ratio [HR] 3.030; 95% CI 3.008–3.053) and congestive heart failure (HR 1.86; 95% CI 1.85–1.88). Patients who were regularly dispensed statins, ace-inhibitors, beta-blockers, antithrombotic agents, and anticoagulants all had lower mortality (range OR 0.36; CI 0.35–0.37 for statins to OR 0.60; CI 0.59–0.61 for anticoagulants; all p < 0.001). Conclusion: Among US Medicare patients diagnosed with PAD between 2006 and 2019, 1-year age-adjusted mortality declined by 2.7%. This decline in mortality among patients with PAD occurred in the context of a younger mean age of diagnosis of PAD and improved cardiovascular prevention therapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Deriving International Classification of Diseases, 9th and 10th revision, codes for identifying and following up patients with diabetic lower extremity ulcers

Author

Fowler, Xavier P., primary, Eid, Mark A., additional, Barnes, J. Aaron, additional, Mehta, Kunal S., additional, Bratches, Reed W., additional, Hu, David, additional, Goodney, Ella, additional, Creager, Mark A., additional, Bonaca, Mark P., additional, Feinberg, Mark W., additional, Moore, Kayla O., additional, Gladders, Barbara, additional, Armstrong, David G., additional, and Goodney, Philip P., additional

Published
2022
Full Text
View/download PDF

11. The Impact of Work Status and Age in Choosing Type of Abdominal Aortic Aneurysm Repair

Author

Hu, Yiyuan David, primary, Jones, James M., additional, Sensenig, Catherine J., additional, Eid, Mark A., additional, Mehta, Kunal, additional, Goldwag, Jenaya L., additional, Barnes, Jonathan A., additional, Moore, Kayla O., additional, Halpern, Vivienne, additional, Henke, Peter, additional, Tang, Gale, additional, Mureebe, Leila, additional, Alabi, Olamide, additional, Tzeng, Edith, additional, Stone, David, additional, Brooke, Benjamin, additional, Nelson, Peter, additional, Spangler, Emily, additional, Barry, Michael, additional, Kang, Ravinder, additional, Scali, Salvatore, additional, O'Connell, Jessica, additional, and Goodney, Philip, additional

Published
2022
Full Text
View/download PDF

14. Effect of a Decision Aid on Agreement Between Patient Preferences and Repair Type for Abdominal Aortic Aneurysm: A Randomized Clinical Trial

Author

Eid, Mark A., Barry, Michael J., Tang, Gale L., Henke, Peter K., Johanning, Jason M., Tzeng, Edith, Scali, Salvatore T., Stone, David H., Suckow, Bjoern D., Lee, Eugene S., Arya, Shipra, Brooke, Benjamin S., Nelson, Peter R., Spangler, Emily L., Murebee, Leila, Dosluoglu, Hasan H., Raffetto, Joseph D., Kougais, Panos, Brewster, Luke P., Alabi, Olamide, Dardik, Alan, Halpern, Vivienne J., O’Connell, Jessica B., Ihnat, Daniel M., Zhou, Wei, Sirovich, Brenda E., Metha, Kunal, Moore, Kayla O., Voorhees, Amy, and Goodney, Philip P.

Abstract

IMPORTANCE: Patients with abdominal aortic aneurysm (AAA) can choose open repair or endovascular repair (EVAR). While EVAR is less invasive, it requires lifelong surveillance and more frequent aneurysm-related reinterventions than open repair. A decision aid may help patients receive their preferred type of AAA repair. OBJECTIVE: To determine the effect of a decision aid on agreement between patient preference for AAA repair type and the repair type they receive. DESIGN, SETTING, AND PARTICIPANTS: In this cluster randomized trial, 235 patients were randomized at 22 VA vascular surgery clinics. All patients had AAAs greater than 5.0 cm in diameter and were candidates for both open repair and EVAR. Data were collected from August 2017 to December 2020, and data were analyzed from December 2020 to June 2021. INTERVENTIONS: Presurgical consultation using a decision aid vs usual care. MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion of patients who had agreement between their preference and their repair type, measured using χ2 analyses, κ statistics, and adjusted odds ratios. RESULTS: Of 235 included patients, 234 (99.6%) were male, and the mean (SD) age was 73 (5.9) years. A total of 126 patients were enrolled in the decision aid group, and 109 were enrolled in the control group. Within 2 years after enrollment, 192 (81.7%) underwent repair. Patients were similar between the decision aid and control groups by age, sex, aneurysm size, iliac artery involvement, and Charlson Comorbidity Index score. Patients preferred EVAR over open repair in both groups (96 of 122 [79%] in the decision aid group; 81 of 106 [76%] in the control group; P = .60). Patients in the decision aid group were more likely to receive their preferred repair type than patients in the control group (95% agreement [93 of 98] vs 86% agreement [81 of 94]; P = .03), and κ statistics were higher in the decision aid group (κ = 0.78; 95% CI, 0.60-0.95) compared with the control group (κ = 0.53; 95% CI, 0.32-0.74). Adjusted models confirmed this association (odds ratio of agreement in the decision aid group relative to control group, 2.93; 95% CI, 1.10-7.70). CONCLUSIONS AND RELEVANCE: Patients exposed to a decision aid were more likely to receive their preferred AAA repair type, suggesting that decision aids can help better align patient preferences and treatments in major cardiovascular procedures. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03115346

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results